photo of Dr. Amelie G. Ramirez, UT Health San Antonio

Amelie G. Ramirez to lead Women in Cancer Research Council

November 10, 2021

Amelie G. Ramirez, DrPH, MPH, director of Salud America! at UT Health San Antonio and a leading health disparities researcher, has been selected to serve as the 2021-2022 chair of the Women in Cancer Research Council of the American Association for Cancer Research (AACR).

Long School of Medicine recognizes outstanding faculty

November 9, 2021

The University of Texas Health Science Center at San Antonio’s Joe R. and Teresa Lozano Long School of Medicine announced its faculty awards during the annual faculty assembly and Dean’s town hall meeting held virtually in October.

Office of the Vice President for Research Virtual Town Hall Series

November 5, 2021

The mission of the Office of the Vice President for Research is to support the research enterprise. In service to our world-class investigators and their research teams, we provide services and resources to advance our research environment.

Sudha Seshadri, MD, founding director of the Biggs Institute

A personal take on dementia care, prevention

November 5, 2021

For Sudha Seshadri, MD, professor of neurology and the founding director of the Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases, fighting for brain health is personal.

Image of COVID-19 Coronavirus Infections Viruses

Nationwide study testing ivermectin and other drugs conducted at UT Health San Antonio

November 5, 2021

A large, multi-site study funded by the National Institutes of Health aims to test the effectiveness of three existing drugs, including controversial ivermectin, to treat the symptoms of COVID-19. Known as ACTIV-6, the study is now underway at UT Health San Antonio.

close-up roller with inlays and drops of white paint used to show possible chemical exposure.

Study validates quick screening for chemical intolerance, finds one in five affected

November 4, 2021

A recent study validates use of a brief questionnaire to screen patients for chemical intolerance, after a large national sampling, and the researchers conclude the condition likely affects one in five people.